indazoles and osmium
indazoles has been researched along with osmium in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Arion, VB; Büchel, GE; Hejl, M; Jakupec, MA; Keppler, BK; Stepanenko, IN | 2 |
| Arion, VB; Berger, W; Büchel, GE; Heffeter, P; Hejl, M; Jakupec, MA; Keppler, BK; Stepanenko, IN | 1 |
| Arion, VB; Büchel, GE; Filipović, L; Jovanović, KK; Kuhn, PS; Radulović, S; Rapta, P | 1 |
| Arion, VB; Bačić, G; Dömötör, O; Enyedy, EA; Kuhn, PS; Popović-Bijelić, A; Rathgeb, A | 1 |
| Arion, VB; Büchel, GE; Bucinsky, L; Eppinger, J; Komorovsky, S; Kossatz, S; Rapta, P; Reiner, T; Sadique, A; Telser, J; Zalibera, M | 1 |
Other Studies
6 other study(ies) available for indazoles and osmium
| Article | Year |
|---|---|
[Os(IV)Cl(5)(Hazole)](-) complexes: synthesis, structure, spectroscopic properties, and antiproliferative activity.
Topics: Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Electrochemistry; Humans; Hydrolysis; Indazoles; Magnetic Resonance Spectroscopy; Magnetics; Organometallic Compounds; Osmium; Pyrazoles; Solubility; Water | 2009 |
En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Electrochemistry; Humans; Indazoles; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Conformation; Organometallic Compounds; Osmium; Ruthenium Compounds | 2011 |
Osmium(IV) complexes with 1H- and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Dose-Response Relationship, Drug; Humans; Indazoles; Isomerism; Magnetic Resonance Spectroscopy; Mice; Mice, SCID; Neoplasms; Osmium; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Tumor Burden; X-Ray Diffraction; Xenograft Model Antitumor Assays | 2012 |
Osmium(III) analogues of KP1019: electrochemical and chemical synthesis, spectroscopic characterization, X-ray crystallography, hydrolytic stability, and antiproliferative activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electrochemical Techniques; HeLa Cells; Humans; Hydrolysis; Indazoles; Models, Molecular; Molecular Structure; Organometallic Compounds; Osmium; Ruthenium Compounds; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2014 |
Investigation of the binding of cis/trans-[MCl4(1H-indazole)(NO)](-) (M = Ru, Os) complexes to human serum albumin.
Topics: Humans; Indazoles; Organometallic Compounds; Osmium; Ruthenium; Serum Albumin | 2016 |
cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; HEK293 Cells; HT29 Cells; Humans; Indazoles; Isomerism; Molecular Conformation; Organometallic Compounds; Osmium; Quantum Theory; Ruthenium; Ruthenium Compounds | 2017 |